Of note, CD68+ human leukocyte antigen (HLA)-DR+ M1-TAMs promoted carcinoma cell movement through the activation of NF-κB/focal adhesion kinase (FAK) signaling (Wang et al., 2014). The gene discussed is NFKB1; the disease is carcinoma.